Da Hee Han, PharmD

The CPSC has issued a safety statement regarding the new must-have product of the season: hoverboards.

A safety review conducted by the Food and Drug Administration (FDA) has led to new warnings added to the prescribing information for sodium-glucose co-transporter 2 (SGLT2) inhibitors used to treat type 2 diabetes.

Isovaline may be a new alternative to opioids for anesthesia and procedural sedation, new data published in Anesthesia & Analgesia has shown.

The Food and Drug Administration (FDA) is warning that use of dipeptidyl peptidase-4 (DPP-4) inhibitors may cause joint pain which could be severe and disabling.

Cefaly transcutaneous electrical nerve stimulation (TENS) device provided relief to 81 percent of migraine sufferers who used it, according to results of a clinical study published in The Journal of Headache and Pain.

A nationwide survey showed that female physicians made close to $15,000 less than male physicians.

FDA has approved Zecuity (sumatriptan iontophoretic transdermal system) for the acute treatment of migraine with or without aura in adults.